Double-Blind Naltrexone in Compulsive Sexual Behavior

Completed · Phase 2 · Has a placebo group

Conditions studied: Compulsive Sexual Behavior

In brief

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Key facts

Study ID
NCT00467558
Run by
University of Minnesota
People needed
7
Starts
2007-05-01
Expected to finish
2010-06-01
Last updated by the study team
2012-05-18

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.